Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsFresenius oncology

    Fresenius Oncology

    Jump to

    • SAT order on Fresenius Kabi anti-investor: JN Gupta

      The SAT's order on Tuesday to give its nod to Fresenius Oncology for delisting its shares without having the need to go ahead with the stiff conditions put forth by the Sebi is anti-investor and patently wrong, belives JN Gupta.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347